<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To investigate a case of a young woman with both <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> who developed multiple <z:hpo ids='HP_0007985'>retinal arteriolar occlusions</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Case report of a 25-year-old woman with history and laboratory tests confirming the diagnosis of both <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> who presented with <z:hpo ids='HP_0000622'>blurred vision</z:hpo> in both eyes </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Multiple <z:hpo ids='HP_0007985'>retinal arteriolar occlusions</z:hpo> were observed in both of her eyes </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was treated first with <z:chebi fb="5" ids="28304">heparin</z:chebi> and then with <z:chebi fb="8" ids="10033">warfarin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">Primary antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, as well as other forms of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo>, should be considered in the differential diagnosis of unexplained <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The coexistence of several thrombophilic disorders may carry a particularly high risk for thrombotic manifestations </plain></SENT>
</text></document>